125 related articles for article (PubMed ID: 36907260)
1. Role of 5-HT
Esaki H; Sasaki Y; Nishitani N; Kamada H; Mukai S; Ohshima Y; Nakada S; Ni X; Deyama S; Kaneda K
Eur J Pharmacol; 2023 May; 946():175653. PubMed ID: 36907260
[TBL] [Abstract][Full Text] [Related]
2. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
Morley KC; Arnold JC; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
[TBL] [Abstract][Full Text] [Related]
3. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635.
Hunt GE; McGregor IS; Cornish JL; Callaghan PD
Brain Res Bull; 2011 Aug; 86(1-2):65-73. PubMed ID: 21745546
[TBL] [Abstract][Full Text] [Related]
4. Looking for prosocial genes: ITRAQ analysis of proteins involved in MDMA-induced sociability in mice.
Kuteykin-Teplyakov K; Maldonado R
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1773-83. PubMed ID: 25241352
[TBL] [Abstract][Full Text] [Related]
5. 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221.
Conductier G; Crosson C; Hen R; Bockaert J; Compan V
Neuropsychopharmacology; 2005 Jun; 30(6):1056-63. PubMed ID: 15668722
[TBL] [Abstract][Full Text] [Related]
6. A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy").
Thompson MR; Callaghan PD; Hunt GE; Cornish JL; McGregor IS
Neuroscience; 2007 May; 146(2):509-14. PubMed ID: 17383105
[TBL] [Abstract][Full Text] [Related]
7. Repeated administration of the 5-HT₁B/₁A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT₁A and 5-HT₁B receptor mechanisms.
Aronsen D; Bukholt N; Schenk S
Psychopharmacology (Berl); 2016 Apr; 233(8):1339-47. PubMed ID: 26856853
[TBL] [Abstract][Full Text] [Related]
8. 3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner.
Pitts EG; Minerva AR; Chandler EB; Kohn JN; Logun MT; Sulima A; Rice KC; Howell LL
Neuropsychopharmacology; 2017 Sep; 42(10):1962-1971. PubMed ID: 28425496
[TBL] [Abstract][Full Text] [Related]
9. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
Ramos M; Goñi-Allo B; Aguirre N
Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
[TBL] [Abstract][Full Text] [Related]
10. Serotonin antagonists fail to alter MDMA self-administration in rats.
Schenk S; Foote J; Aronsen D; Bukholt N; Highgate Q; Van de Wetering R; Webster J
Pharmacol Biochem Behav; 2016 Sep; 148():38-45. PubMed ID: 27264435
[TBL] [Abstract][Full Text] [Related]
11. Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors.
Millan MJ; Colpaert FC
Eur J Pharmacol; 1991 Feb; 193(2):145-52. PubMed ID: 1675609
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic modulation of basolateral amygdala nucleus in the extinction of reward-driven learning: The role of 5-HT bioavailability and 5-HT
Pereyra AE; Mininni CJ; Zanutto BS
Behav Brain Res; 2021 Apr; 404():113161. PubMed ID: 33571570
[TBL] [Abstract][Full Text] [Related]
13. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
Ball KT; Rebec GV
Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
[TBL] [Abstract][Full Text] [Related]
14. The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.
Kamilar-Britt P; Bedi G
Neurosci Biobehav Rev; 2015 Oct; 57():433-46. PubMed ID: 26408071
[TBL] [Abstract][Full Text] [Related]
15. Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.
Renoir T; Païzanis E; El Yacoubi M; Saurini F; Hanoun N; Melfort M; Lesch KP; Hamon M; Lanfumey L
Int J Neuropsychopharmacol; 2008 Dec; 11(8):1149-62. PubMed ID: 18611291
[TBL] [Abstract][Full Text] [Related]
16. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
Mlinar B; Corradetti R
Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
[TBL] [Abstract][Full Text] [Related]
17. MDMA induces EPSP-Spike potentiation in rat ventral hippocampus in vitro via serotonin and noradrenaline release and coactivation of 5-HT4 and beta1 receptors.
Mlinar B; Mascalchi S; Morini R; Giachi F; Corradetti R
Neuropsychopharmacology; 2008 May; 33(6):1464-75. PubMed ID: 17653110
[TBL] [Abstract][Full Text] [Related]
18. Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats.
Thompson MR; Callaghan PD; Hunt GE; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1013-21. PubMed ID: 18302974
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
McCreary AC; Bankson MG; Cunningham KA
J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
